ClearPoint Neuro (CLPT) Enterprise Value Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.31% |
| Dec 31, 2025 | -17.97% |
| Sep 30, 2025 | -21.10% |
| Jun 30, 2025 | -20.95% |
| Mar 31, 2025 | 6.11% |
| Dec 31, 2024 | -28.69% |
| Sep 30, 2024 | -28.18% |
| Jun 30, 2024 | -34.50% |
| Mar 31, 2024 | -70.02% |
| Dec 31, 2023 | -49.48% |
| Sep 30, 2023 | -45.62% |
| Jun 30, 2023 | -31.66% |
| Mar 31, 2023 | -33.40% |
| Dec 31, 2022 | -32.20% |
| Dec 31, 2021 | -74.79% |
| Sep 30, 2021 | -67.04% |
| Jun 30, 2021 | -98.11% |
| Mar 31, 2021 | -78.47% |
| Dec 31, 2020 | -30.02% |
| Sep 30, 2020 | -51.26% |
| Jun 30, 2020 | -35.42% |
| Mar 31, 2020 | -21.40% |
| Dec 31, 2019 | 9.23% |
| Sep 30, 2019 | -26.90% |
| Jun 30, 2019 | -12.85% |
| Mar 31, 2019 | 15.55% |
| Dec 31, 2018 | 2.48% |
| Sep 30, 2018 | 5.91% |
| Jun 30, 2018 | 0.82% |
| Mar 31, 2018 | 3.97% |
| Dec 31, 2017 | -41.81% |
| Dec 31, 2016 | -86.88% |
| Sep 30, 2016 | -129.19% |
| Jun 30, 2016 | -27.54% |
| Mar 31, 2016 | -232.14% |